Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers

Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers

Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) ...

Full description

Bibliographic Details
Main Authors:	Hawkar Qadir Baiz, Tavga Ahmed Aziz, Dana Ahmed Sharif
Format:	Article
Language:	English
Published:	College of Pharmacy / Mustansiriyah University 2020-06-01
Series:	Al-Mustansiriyah Journal of Pharmaceutical Sciences
Subjects:	CKD-MBD, Pharmaceutical care, biochemical parameters, QoL, DRPs
Online Access:	https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/689

Similar Items

Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease
by: Ariane Zaloszyc, et al.
Published: (2023-03-01)

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects
by: Jordi Bover, et al.
Published: (2021-05-01)

Risk factors and implications associated with renal mineralization in chronic kidney disease in cats
by: Pak‐Kan Tang, et al.
Published: (2022-03-01)

Quality of life tools among patients on dialysis: A systematic review
by: Mohammad H. Aljawadi, et al.
Published: (2024-03-01)

The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
by: Giuseppe Cianciolo, et al.
Published: (2020-06-01)

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
by: Kanda Eiichiro, et al.
Published: (2012-09-01)

Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study
by: Xueqing Tang, et al.
Published: (2022-12-01)

Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic
by: Lilio Hu, et al.
Published: (2022-10-01)

Sleep Apnea in Maintenance Hemodialysis: A Mixed-Methods Study
by: Ginger Chu, et al.
Published: (2020-07-01)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
by: Rupinder Kaur, et al.
Published: (2023-10-01)

Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis
by: Daijo Inaguma, et al.
Published: (2018-04-01)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
by: Hirosumi Miyakawa, et al.
Published: (2021-09-01)

Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
by: José-Vicente Torregrosa, et al.
Published: (2023-06-01)

Modifying Phosphate Toxicity in Chronic Kidney Disease
by: Marc Vervloet
Published: (2019-09-01)

Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012‐2018)
by: Dirk Hendrik Nicolaas van denBroek, et al.
Published: (2022-07-01)

Machine learning based biomarker discovery for chronic kidney disease–mineral and bone disorder (CKD-MBD)
by: Yuting Li, et al.
Published: (2024-02-01)

A feasibility study of avoiding positive calcium balance and parathyroid hormone increase in patients on peritoneal dialysis
by: Maria Clara Teixeira Piraciaba, et al.
Published: (2022-12-01)

Relative comparison of chronic kidney disease-mineral and bone disorder rat models
by: Xiaoqiong Zhang, et al.
Published: (2023-02-01)

Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies
by: Daniela F. Cardoso, et al.
Published: (2020-08-01)

Drug-related problems and clinical risk factors relationship in hepatic cirrhosis patients
by: Amelia Lorensia, et al.
Published: (2011-07-01)

Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside
by: Kosaku Nitta, et al.
Published: (2023-01-01)

Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows
by: Julia Martín-Vírgala, et al.
Published: (2024-02-01)

Emerging Effects of Sevelamer in Chronic Kidney Disease
by: Ryota Ikee, et al.
Published: (2013-03-01)

A Role of Intestinal Alkaline Phosphatase 3 (Akp3) in Inorganic Phosphate Homeostasis
by: Shohei Sasaki, et al.
Published: (2018-09-01)

Cortical porosity occurs at varying degrees throughout the skeleton in rats with chronic kidney disease
by: Corinne E. Metzger, et al.
Published: (2022-12-01)

CKD 5D Asia—what is common and what is different from the West?
by: Kunitoshi Iseki
Published: (2018-09-01)

The Importance of Phosphate Control in Chronic Kidney Disease
by: Ken Tsuchiya, et al.
Published: (2021-05-01)

Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica: 2021 (SEN-MM)
by: José-Vicente Torregrosa, et al.
Published: (2022-12-01)

Fatigue assessment and its predictors in pediatric patients with chronic kidney disease stages III to V
by: Yasmin Ramadan, et al.
Published: (2023-01-01)

A Changing Perspective for Treatment of Chronic Kidney Disease
by: Giacomo Garibotto
Published: (2021-08-01)

Bone Disease in Chronic Kidney Disease and Kidney Transplant
by: Ezequiel Bellorin-Font, et al.
Published: (2022-12-01)

Serum fatty acid binding protein 4 levels are associated with abdominal aortic calcification in peritoneal dialysis patients
by: Sijia Zhou, et al.
Published: (2021-01-01)

Psychological quality of life and its association with academic employability skills among newly-registered students from three European faculties
by: Ionescu Ion, et al.
Published: (2011-04-01)

Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
by: Paola Monciino, et al.
Published: (2022-09-01)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
by: Cozzolino M, et al.
Published: (2017-06-01)

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
by: Matthew J. Damasiewicz, et al.
Published: (2018-11-01)

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism
by: Chihiro Kato, et al.
Published: (2020-10-01)

The Evolving World of Chronic Kidney Disease Mineral Bone Disorder
by: Antonio Bellasi, et al.
Published: (2013-07-01)

Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines
by: Jordi Bover, et al.
Published: (2023-03-01)

Time-Varying Risk Factors for Incident Fractures in Kidney Transplant Recipients: A Nationwide Cohort Study in South Korea
by: Sang Hun Eum, et al.
Published: (2023-03-01)